cardiotoxicity

HOUSTON, May 15, 2026 Moleculin Biotech reported first quarter 2026 financial results while advancing its pivotal MIRACLE Phase 2B/3...

Chicago, USA – March 26, 2026 GE HealthCare announced a leading industrial role in the €50.5 million COMPASS consortium,...